SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000827809-17-000006
Filing Date
2017-03-15
Accepted
2017-03-15 07:14:21
Documents
4
Period of Report
2017-03-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvln-12312016pressreleasef.htm 8-K 39658
2 EXHIBIT 99.1 nvln-12312016pressrelease_.htm EX-99.1 273646
3 EXHIBIT 99.2 nvln-12312016rfsandlps_992.htm EX-99.2 421330
4 logo.jpg GRAPHIC 17598
  Complete submission text file 0000827809-17-000006.txt   760619
Mailing Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 250 VANCOUVER A1 V5T 4T5 6047077000
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17082 | Film No.: 17689825
SIC: 2834 Pharmaceutical Preparations